Researchers develop ‘Goldilocks drug’ to treat triple-negative breast cancer
Researchers have developed a drug that so specifically targets a deadly kind of breast cancer that there are little to no toxic side effects. Next, it will be tested in phase 1 clinical trials in humans.
Read Original Article: Researchers develop ‘Goldilocks drug’ to treat triple-negative breast cancer »
